Drug General Information
Drug ID	D05MOZ
Former ID	DNCL002205
Drug Name	G-202
Indication	Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48]		Phase 2	[524201]
Company	GenSpera
Structure		Download 2D MOL
Target and Pathway
Target(s)	Glutamate carboxypeptidase II	Target Info	Inhibitor	[550453]
KEGG Pathway	Alanine, aspartate and glutamate metabolism
	Metabolic pathways
	Vitamin digestion and absorption
NetPath Pathway	TCR Signaling Pathway
	TNFalpha Signaling Pathway
Reactome	Amino acid synthesis and interconversion (transamination)
WikiPathways	One Carbon Metabolism
References
Ref 524201	ClinicalTrials.gov (NCT01777594) Study of G-202 as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma. U.S. National Institutes of Health.
Ref 550453	National Cancer Institute Drug Dictionary (drug id 666090).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.